George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Don't forget the Expansion into oncology.
New Cannabinoid -based Treatment of Cancer Malignancies.
Worth US$532 billion by 2032.
17th July 2023.
Could be getting news on this soon.
I've had a top up here this morning.
Nothing but buys today!
Looks like it’s about to turn blue.
Would love to get back to 0.5 asap.
Mad that it’s sub placing with so much news due and director buys
Sizes of buys increasing as people realise the opportunity
Just bought a few more 😎
Good post.
We are mostly down here on low liquidity swings, nothing more. I have spoken to the company (who are very good at shareholder communications) they are working on lots in the background and I am led to believe that news will be soon.
Question really is do you want to buy on news or be in ahead of it. That low liquidity will move price up just as fast as it moved it down.
My understanding. The focus this year is on program 2 (the cbd inhaler) as this needs less regulatory hurdles to cross and this is being progressed in Australia. Clarissa believes this will be the first product to hit the market. The other three programs are all being pursued, with preparations for program 1 phase 2 testing next year. A lot of legal and regulatory work is also being done this year so hopefully by the end of the year … program 2 phase 1 complete, program 1 ready for phase 2 with lots of administrative hurdles for the regulators cleared and legal work to protect investment across all 4 programs complete.
We will see a big rebate on news, I also spoke to company and there are no delays.
No confusion BurtonD, my post was regarding OCT 461201 (Prog1), not Prog2 ...
A little more info from the BoD would be useful ?
Opportunity in #OCTP ⁉️
So, looks like a little confusion here over the latest @Edison_Inv_Res note on @OxCanTech (note below)
Not really sure why…
Program 1 is being highlighted in some areas 𝐍𝐎𝐓 program 2 which was the whole point of the fundraise! 🤦🏻♂️
Program 2 is very much set for Q2 2024.
Joined you. No brainwr. 0.5 placing and now sitting at 0.34 to buy.
Managed to get some at 0.33 and 0.34
Happy to wait for an update now
Me too bought another big chunk but not showing .33p
No idea why the drop, sometimes mm's lower the sp trigger shorts prior to positive rns, MM's filling their boots
Just added, got what I want in here now no more top ups unless it really drops gla
No idea but took advantage of it and added.
Why the 15% drop?
Nice there valuation of the company is 2.6p per share.
Thanks for that Syntax.
I hadn't ever seen that and doubt I ever would.
Bought a few just under 0.4 looks a good price.
Bert: this is from the Edison research report, 5th February :
"A key highlight of the period was the successful completion of the Phase I single ascending dose (SAD) safety and tolerability trial for OCT461201 in healthy volunteers (n=32). We understand that a follow-up multiple ascending dose (MAD) study is now planned for early CY25"
Perhaps this is out of date now, if so OCTP can clarify ?
https://www.edisongroup.com/research/early-signs-of-revival-in-clinical-activity/33216/
It goes up from here
Hi Chris, All good here thanks. Just completed a small raise to get our second programme into the clinic and open INDs for both lead programmes so the team is busy working on that at present. Great Phase I results for Programme 1 in October last year too.
I must have missed that Syntax!
Can you point me to where they said they were postponing phase 2 please.
I've scanned through the RNS and can't find it.
Thanks in advance.
"Both are happening"
No they aren't. Prog 1 phase 2 postponed for 12 months.
And unless they are really careful with the australian contract costs, they will likely need another fund raise in a years time too.
Cashed up with news flow coming in the short term
Both are happening
Supposedly just done one. Doesn’t feel like we are going anywhere. Wondered why they didn’t move forward with our first product to phase 2 than another phase 1?